KINGDON CAPITAL MANAGEMENT, L.L.C.
Position in ZVRA — Zevra Therapeutics, Inc.
CIK 1000097
NEW YORK, NY
Position in ZVRA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,223,000
+$1,980,782 QoQ
Shares Held
775,000
+32.5% QoQ
Ownership
1.31%
of shares outstanding
% of Portfolio
1.23%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026KINGDON CAPITAL MANAGEMENT, L.L.C. holds $105,644,873 across 7 Biotechnology names. ZVRA ranks #4 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SNDX |
Syndax Pharmaceuticals Inc
|
2,500,000 | $58,400,000 | |
| 2 | SLNO |
Soleno Therapeutics Inc
|
575,000 | $19,251,000 | |
| 3 | OLMA |
Olema Pharmaceuticals, Inc.
|
855,000 | $12,748,050 | |
| 4 | ZVRA |
Zevra Therapeutics, Inc.
This page
|
775,000 | $7,223,000 | |
| 5 | ALDX |
Aldeyra Therapeutics, Inc.
|
2,152,315 | $3,637,412 | |
| 6 | ELDN |
Eledon Pharmaceuticals, Inc.
|
1,039,275 | $3,200,967 | |
| 7 | JSPR |
Jasper Therapeutics, Inc.
|
1,352,106 | $1,184,444 |
All Filings in ZVRA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,223,000 | 775,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,242,218 | 585,069 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $6,181,500 | 650,000 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,964,500 | 450,000 | Shares | Defined | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||